Anti-Gonadotropin Releasing Hormone Vaccines and Their Potential Use in the Treatment of Hormone-Responsive Cancers

ISSN： 1173-8804

Source： BioDrugs, Vol.12, Iss.1, 1999-07, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conservative therapy with a gonadotropin‐releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 479-482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Potential of Growth Hormone in the Treatment of Congestive Heart Failure

By Isgaard J.

BioDrugs, Vol. 12, Iss. 4, 1999-10 ,pp. : 245-250

Adis International

Access to resources Recommend Favorite

Recombinant Human Growth Hormone: Rationale for Use in the Treatment of HIV-Associated Lipodystrophy

By Benedini Stefano

BioDrugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 101-112

Adis International

Access to resources Recommend Favorite

Parathyroid Hormone in the Treatment of Osteoporosis

By Fujita T.

BioDrugs, Vol. 15, Iss. 11, 2001-01 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite

Effects of Plasmid-Mediated Growth Hormone-Releasing Hormone in Severely Debilitated Dogs with Cancer

By Draghia-Akli R. Hahn K.A. King G.K. Cummings K.K. Carpenter R.H.

Molecular Therapy, Vol. 6, Iss. 6, 2002-12 ,pp. : 830-836

Academic Press

Access to resources Recommend Favorite